Pulmonary Arterial Hypertension (PAH) is a life-threatening, degenerative disease that severely compromises the function of both the pulmonary (lung) and cardiovascular (heart) systems. Despite current treatment options in PAH offering improvements in symptom control and quality of life factors, there continue to be significant challenges that compromise the effective management of this progressive and debilitating condition.
With Thai consumers paying more attention to their health, many investors are focused on the Healthcare market in Thailand as part of their growth plans in the Asia Pacific.
The growth of Indonesia's healthcare industry has been boosted by the newly implemented Universal Health Insurance as more people are gaining access to healthcare facilities.
As the economy continues to grow in Myanmar, one of the areas that has seen a major overhaul is the healthcare industry. The new government in Myanmar has increased government spending on its healthcare budget.
